Key result
African American race is linked to ~2-fold higher fetal death and worse maternal complications in preeclampsia.
Why the study?
African American pregnant women have a high prevalence of preeclampsia, but systemic analyses regarding their complications, etiology, and biomarkers were needed.
African American women with preeclampsia face disproportionately higher rates of severe maternal and fetal complications, highlighting the need for targeted research into etiologies and specific biomarkers to improve clinical management.
Highlights excess preterm birth, fetal death, and maternal mortality risks in African American preeclamptic women; leaves open targeted etiology and biomarker research before changing practice.
Importance Preeclampsia is a devastating disease of pregnancy associated with increased risk of fetal and maternal complications. African American pregnant women have a high prevalence of preeclampsia, but there is a need of systemic analyses of this high-risk group regarding complications, etiology, and biomarkers. Objective The aim of this study was to provide a synopsis of current research of preeclampsia specifically related to African American women. Evidence Acquisition A comprehensive search was performed in the bibliographic database PubMed with keywords “preeclampsia” and “African American.” Results African American women with preeclampsia were at an increased risk of preterm birth, which resulted in low-birth-weight infants. Intrauterine fetal death among African American preeclamptic patients occurs at twice the rate as in other races. On the maternal side, African American mothers with preeclampsia have more severe hypertension, antepartum hemorrhage, and increased mortality. Those who survive preeclampsia have a high risk of postpartum cardiometabolic disease. Preexisting conditions (eg, systemic lupus erythematosus) and genetic mutations (eg, sickle cell disease in the mother, FVL or APOL1 mutations in the fetus) may contribute to the higher prevalence and worse outcomes in African American women. Many blood factors, for example, the ratio of proteins sFlt/PlGF, hormones, and inflammatory factors, have been studied as potential biomarkers for preeclampsia, but their specificity needs further investigation. Conclusions Further studies of preeclampsia among African American women addressing underlying risk factors and etiologies, coupled with identification of preeclampsia-specific biomarkers allowing early detection and intervention, will significantly improve the clinical management of this devastating disease. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be better able to describe the difference in prevalence of fetal and maternal complications among African American women with preeclampsia versus women of other races; explain updated genetic studies of preeclampsia specifically related to African American women; and analyze current research of biomarkers for prediction of status and progress of preeclampsia.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) conducted a review in Preeclampsia. Preeclampsia vs. Other races was evaluated on Fetal and maternal complications. African American women with preeclampsia experience twice the rate of intrauterine fetal death compared to other races, alongside more severe hypertension, hemorrhage, and increased mortality.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: